Drug Standards
- (2)
- (4)
- (1)
- (3)
- (3)
- (665)
- (3)
- (27)
- (1)
- (6)
- (27)
- (61)
- (24)
- (1)
- (2)
- (35)
- (367)
- (45)
- (1)
- (2)
- (1)
- (5)
- (5)
- (4)
- (2)
- (7)
- (1)
- (5)
- (4)
- (3)
- (3)
- (1)
- (3)
- (2)
- (2)
- (1)
- (2)
- (3)
- (4)
- (2)
- (2)
- (1)
- (1)
- (3)
- (1)
- (1)
- (1)
- (4)
- (1)
- (1)
- (1)
- (1)
- (4)
- (3)
- (1)
- (1)
- (2)
- (5)
- (1)
- (2)
- (4)
- (1)
- (1)
- (3)
- (5)
- (3)
- (1)
- (2)
- (1)
- (1)
- (1)
- (3)
- (1)
- (1)
- (3)
- (4)
- (2)
- (2)
- (1)
- (4)
- (4)
- (5)
- (3)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (3)
- (4)
- (3)
- (1)
- (4)
- (1)
- (2)
- (1)
- (5)
- (2)
- (2)
- (1)
- (5)
- (7)
- (3)
- (1)
- (1)
- (1)
- (4)
- (1)
- (3)
- (1)
- (4)
- (1)
- (8)
- (2)
- (1)
- (5)
- (13)
- (1)
- (2)
- (1)
- (1)
- (1)
- (2)
- (4)
- (1)
- (5)
- (1)
- (1)
- (2)
- (1)
- (6)
- (2)
- (1)
- (2)
- (2)
- (1)
- (3)
- (1)
- (2)
- (2)
- (1)
- (1)
- (3)
- (3)
- (1)
- (1)
- (2)
- (3)
- (1)
- (1)
- (1)
- (2)
- (4)
- (3)
- (1)
- (1)
- (5)
- (3)
- (2)
- (5)
- (1)
- (3)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (2)
- (2)
- (1)
- (2)
- (2)
- (4)
- (4)
- (1)
- (2)
- (2)
- (1)
- (2)
- (4)
- (5)
- (2)
- (1)
- (3)
- (2)
- (2)
- (11)
- (1)
- (2)
- (2)
- (2)
- (5)
- (5)
- (4)
- (2)
- (4)
- (2)
- (1)
- (2)
- (5)
- (2)
- (2)
- (1)
- (2)
- (3)
- (2)
- (2)
- (5)
- (3)
- (2)
- (2)
- (1)
- (4)
- (3)
- (1)
- (1)
- (2)
- (2)
- (3)
- (2)
- (2)
- (3)
- (2)
- (1)
- (1)
- (5)
- (1)
- (2)
- (5)
- (5)
- (2)
- (1)
- (1)
- (2)
- (2)
- (1)
- (1)
- (7)
- (2)
- (2)
- (1)
- (3)
- (1)
- (3)
- (2)
- (5)
- (2)
- (2)
- (2)
- (2)
- (5)
- (2)
- (1)
- (6)
- (3)
- (2)
- (1)
- (5)
- (5)
- (2)
- (2)
- (1)
- (6)
- (1)
- (1)
- (1)
- (1)
- (5)
- (1)
- (2)
- (4)
- (1)
- (3)
- (1)
- (1)
- (2)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (2)
- (2)
- (1)
- (2)
- (1)
- (1)
- (5)
- (2)
- (2)
- (1)
- (1)
- (2)
- (8)
- (4)
- (14)
- (7)
- (8)
- (1)
- (3)
- (1)
- (6)
- (1)
- (1)
- (5)
- (2)
- (1)
- (1)
- (2)
- (20)
- (4)
- (5)
- (1)
- (3)
- (2)
- (1)
- (7)
- (8)
- (7)
- (2)
- (1)
- (2)
- (1)
- (3)
- (5)
- (5)
- (1)
- (3)
- (1)
- (3)
- (6)
- (3)
- (3)
- (1)
- (2)
- (26)
- (54)
- (5)
- (11)
- (4)
- (6)
- (6)
- (16)
- (1)
- (129)
- (3)
- (1)
- (2)
- (5)
- (4)
- (14)
- (38)
- (3)
- (13)
- (12)
- (7)
- (1)
- (6)
- (6)
- (6)
- (1)
- (1)
- (1)
- (1)
- (1)
- (12)
- (38)
- (5)
- (1)
- (2)
- (1)
- (1)
- (12)
- (2)
- (15)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (6)
- (15)
- (2)
- (1)
- (19)
- (3)
- (18)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (29)
- (3)
- (2)
- (1)
- (2)
- (1)
- (1)
- (6)
- (1)
- (1)
- (1)
- (1)
- (44)
- (2)
- (27)
- (1)
- (73)
- (6)
- (73)
Filtered Search Results
CERILLIANT™ S(+)-Amphetamine (dextro-Amphetamine) Solution, Sold by MilliporeSigma™ Supelco™
Suitable for use in urine drug testing, clinical toxicology, forensic analysis, and isomer identification by LC-MS/MS or GC/MS.
CERILLIANT™ Multicomponent Alcohol Mix 1000, 1000 μg/mL each component in H2O, Sold by MilliporeSigma™ Supelco™
A multicomponent calibration kit containing acetone, ethanol, isopropanol, and methanol at a concentration of 1000 μg/mL. This kit is suitable for calibration of blood alcohol testing methods using GC Headspace.
Tibolone Impurity Standard, British Pharmacopoeia (BP) Reference Standard, MilliporeSigma™ Supelco™
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets, has been developed and issued under the Authority of the issuing Pharmacopoeia.
CERILLIANT™ Remifentanil acid Solution, 100 μg/mL in Acetonitrile, Sold by MilliporeSigma™ Supelco™
Certified reference material
Methapyrilene HCl, MilliporeSigma™ Supelco™
Methapyrilene is an H1-receptor antihistamine that is known to cause periportal hepatic necrosis following acute high dose administration to the rat subjects in in vitro studies carried out for the identification of mutagens and/or carcinogens.
CERILLIANT™ (±)-Amphetamine-d11 Solution, 100 μg/mL in Methanol, Sold by MilliporeSigma™ Supelco™
Suitable for quantitation of amphetamine levels in urine, serum, or plasma by LC/MS or GC/MS for urine drug testing, clinical toxicology, forensic analysis, or sports testing.
CERILLIANT™ Cannabinol Solution, 1.0 mg/mL in methanol, Sold by MilliporeSigma™ Supelco™
This analytical reference standard is suitable in LC/MS or GC/MS testing methods for applications in urine drug testing, clinical toxicology, pharmaceutical research, and forensic analysis.
Amoxicillin Trihydrate 98.0+%, TCI America™
CAS: 61336-70-7 Molecular Formula: C16H25N3O8S Molecular Weight (g/mol): 419.449 MDL Number: MFCD00072029 InChI Key: MQXQVCLAUDMCEF-FXHJIJKUSA-N PubChem CID: 124080955 IUPAC Name: (2S,5R,6S)-6-[[(2S)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;trihydrate SMILES: CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C.O.O.O
| PubChem CID | 124080955 |
|---|---|
| CAS | 61336-70-7 |
| Molecular Weight (g/mol) | 419.449 |
| MDL Number | MFCD00072029 |
| SMILES | CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C.O.O.O |
| IUPAC Name | (2S,5R,6S)-6-[[(2S)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;trihydrate |
| InChI Key | MQXQVCLAUDMCEF-FXHJIJKUSA-N |
| Molecular Formula | C16H25N3O8S |
Bromfenac sodium, Thermo Scientific™
CAS: 91714-93-1 Molecular Formula: C15H11BrNNaO3 Molecular Weight (g/mol): 356.15 MDL Number: MFCD03701673 InChI Key: HZFGMQJYAFHESD-UHFFFAOYSA-M IUPAC Name: sodium 2-[2-amino-3-(4-bromobenzoyl)phenyl]acetate SMILES: [Na+].NC1=C(CC([O-])=O)C=CC=C1C(=O)C1=CC=C(Br)C=C1
| CAS | 91714-93-1 |
|---|---|
| Molecular Weight (g/mol) | 356.15 |
| MDL Number | MFCD03701673 |
| SMILES | [Na+].NC1=C(CC([O-])=O)C=CC=C1C(=O)C1=CC=C(Br)C=C1 |
| IUPAC Name | sodium 2-[2-amino-3-(4-bromobenzoyl)phenyl]acetate |
| InChI Key | HZFGMQJYAFHESD-UHFFFAOYSA-M |
| Molecular Formula | C15H11BrNNaO3 |
Ketorolac tromethamine, Thermo Scientific™
CAS: 74103-07-4 Molecular Formula: C19H24N2O6 Molecular Weight (g/mol): 376.41 MDL Number: 00887595 InChI Key: BWHLPLXXIDYSNW-UHFFFAOYNA-N IUPAC Name: 2-amino-2-(hydroxymethyl)propane-1,3-diol; 5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid SMILES: NC(CO)(CO)CO.OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1
| CAS | 74103-07-4 |
|---|---|
| Molecular Weight (g/mol) | 376.41 |
| MDL Number | 00887595 |
| SMILES | NC(CO)(CO)CO.OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1 |
| IUPAC Name | 2-amino-2-(hydroxymethyl)propane-1,3-diol; 5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid |
| InChI Key | BWHLPLXXIDYSNW-UHFFFAOYNA-N |
| Molecular Formula | C19H24N2O6 |
Invitrogen™ Nivolumab Recombinant Monoclonal Antibody
Greener Choice
Offers one or more environmental benefits itemized in the U.S. FTC Green Guides.
Learn More
Offers one or more environmental benefits itemized in the U.S. FTC Green Guides.
Learn More
Recombinant Monoclonal Antibody
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Content And Storage | -20°C, Avoid Freeze/Thaw Cycles |
|---|---|
| Target Species | Human |
| Host Species | Human |
| Conjugate | Unconjugated |
| Applications | ELISA,Flow Cytometry,Functional Assay,Surface Plasmon Resonance |
| Form | Lyophilized |
| Isotype | IgG4SP |
| Concentration | 1 mg/mL |
| Antigen | Nivolumab |
| Regulatory Status | RUO |
| Purification Method | Protein A |
| Gene Alias | BMS-936558; MDX-1106; ONO-4538; Opdivo |
| Product Type | Antibody |
| Formulation | 25mM histidine with 8% sucrose, 0.01% Tween 80 and no preservative; pH 6.2 |
| Classification | Recombinant Monoclonal |
| Primary or Secondary | Primary |
Montelukast sodium, 98%
CAS: 151767-02-1 Molecular Formula: C35H35ClNNaO3S Molecular Weight (g/mol): 608.17 MDL Number: MFCD00931431 InChI Key: LBFBRXGCXUHRJY-HKHDRNBDSA-M PubChem CID: 23663996 ChEBI: CHEBI:6993 IUPAC Name: sodium;2-[1-[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetate SMILES: [Na+].CC(C)(O)C1=CC=CC=C1CC[C@@H](SCC1(CC([O-])=O)CC1)C1=CC=CC(\C=C\C2=CC=C3C=CC(Cl)=CC3=N2)=C1
| PubChem CID | 23663996 |
|---|---|
| CAS | 151767-02-1 |
| Molecular Weight (g/mol) | 608.17 |
| ChEBI | CHEBI:6993 |
| MDL Number | MFCD00931431 |
| SMILES | [Na+].CC(C)(O)C1=CC=CC=C1CC[C@@H](SCC1(CC([O-])=O)CC1)C1=CC=CC(\C=C\C2=CC=C3C=CC(Cl)=CC3=N2)=C1 |
| IUPAC Name | sodium;2-[1-[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetate |
| InChI Key | LBFBRXGCXUHRJY-HKHDRNBDSA-M |
| Molecular Formula | C35H35ClNNaO3S |